Micafungin: new drug. Severe candidiasis: a third echinocandin, with life-threatening hepatotoxicity.
D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D002177:Candidiasis / Q000188:drug therapy*; D004311:Double-Blind Method; D017277:Drug Approval; D064420:Drug-Related Side Effects and Adverse Reactions; D054714:Echinocandins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use* / Q000633:toxicity; D005060:Europe; D006801:Humans; D055666:Lipopeptides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use* / Q000633:toxicity; D017093:Liver Failure / Q000139:chemically induced; D000077551:Micafungin; D016032:Randomized Controlled Trials as Topic
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D000077551:Micafungin